Quantum Cyber N.V. SEC filings QUCY
Quantum Cyber N.V. has 204 filings in SEC EDGAR's recent list, going back to Aug 3, 2021. Its latest annual report, Form ARS, was filed on Jun 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jun 15, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2026 | — |
| CORRESP | Letter to the SEC | Jun 12, 2026 | — |
| EFFECT | Filing | Dec 29, 2025 | — |
| CORRESP | Letter to the SEC | Dec 22, 2025 | — |
| EFFECT | Filing | Aug 4, 2025 | — |
| CORRESP | Letter to the SEC | Jul 31, 2025 | — |
| CORRESP | Letter to the SEC | Jul 31, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2025 | — |
| DRS | Filing | Jul 15, 2025 | — |
| EFFECT | Filing | May 16, 2025 | — |
| CORRESP | Letter to the SEC | May 14, 2025 | — |
| CORRESP | Letter to the SEC | May 14, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2025 | — |
| DRS | Filing | Apr 9, 2025 | — |
| EFFECT | Filing | Dec 12, 2024 | — |
| CORRESP | Letter to the SEC | Dec 11, 2024 | — |
| CORRESP | Letter to the SEC | Dec 11, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 8, 2024 | — |
| D/A | Filing | May 10, 2024 | — |
| D | Filing | Jul 11, 2023 | — |
| EFFECT | Filing | Jan 6, 2023 | — |
| CORRESP | Letter to the SEC | Jan 5, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 4, 2023 | — |
| NT 20-F | Notification of late filing | May 2, 2022 | Dec 31, 2021 |
| EFFECT | Filing | Jan 25, 2022 | — |
| CORRESP | Letter to the SEC | Jan 24, 2022 | — |
| CORRESP | Letter to the SEC | Jan 24, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 20, 2022 | — |
| DRS | Filing | Jan 14, 2022 | — |
| EFFECT | Filing | Nov 4, 2021 | — |
| CERT | Filing | Nov 3, 2021 | — |
| 8-A12B | For registration of certain classes | Nov 3, 2021 | — |
| CORRESP | Letter to the SEC | Nov 2, 2021 | — |
| CORRESP | Letter to the SEC | Nov 2, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 21, 2021 | — |
| CORRESP | Letter to the SEC | Oct 8, 2021 | — |
| D | Filing | Sep 8, 2021 | — |
| DRSLTR | Filing | Sep 3, 2021 | — |
| DRS/A | Filing | Sep 3, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 25, 2021 | — |
| DRS | Filing | Aug 3, 2021 | — |
Showing 42 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- QUCY (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Mainz
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1874252
- Former names
- MAINZ BIOMED N.V. (until Apr 15, 2026); Mainz Biomed B.V. (until Nov 12, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.